Workflow
高盛:上调药明康德目标价至74.9港元 上调2025至27年纯利预测
603259WuXi AppTec(603259) 快讯·2025-04-30 04:46

Group 1 - Goldman Sachs raised the target price for WuXi AppTec to HKD 74.9, up from HKD 70.9, maintaining a "Neutral" rating [1] - The company reported strong Q1 performance, and management has maintained its guidance for FY 2025, aligning with Goldman Sachs' expectations [1] - If the company continues its strong performance in the next 1-2 quarters, there is potential for an upward revision of guidance in the second half of the year [1] Group 2 - Goldman Sachs expects the TIDES business to grow by 65% this year, surpassing the official guidance of 60% [1] - The revenue forecasts for the TIDES business for 2025 to 2027 have been increased by 3.1%, 5%, and 5% respectively [1] - The profit forecasts for 2025 to 2027 have been raised by 7%, 3.5%, and 2.3% respectively, reflecting better-than-expected performance in TIDES and small molecule R&D and manufacturing [1]